the ipha stakeholder handbook - section 1 to 2

medicinesan investment in health

The Stakeholder HandbookYour Pharmaceutical Industry Reference Source

2

The Irish Pharmaceutical Healthcare Association (IPHA), the

representative body for the research-based pharmaceutical industry

in Ireland, has compiled the Stakeholder Handbook with a view to

providing assistance to interested parties with enquiries relating to

the industry.

In the following sections you will find listings of key contacts within

IPHA, IPHA member companies, Government, health and enterprise

agencies, regulatory bodies, professional healthcare and enterprise

organisations, voluntary healthcare organisations, patient

organisations, international pharmaceutical associations and other

global healthcare groups.

In addition to key contacts within each of the above listed

organisations the Stakeholder Handbook also provides key facts and

figures relating to the Irish pharmaceutical and healthcare sectors.

IPHA Stakeholder Handbook

First Edition

3

The purpose of the Stakeholder Handbook is to provide a

comprehensive guide to company and industry resources in

order to help answer any queries you may have relating to the

prescription medicines and/or consumer healthcare industries.

We hope that you find this source of use in the coming year and

we welcome your calls on any industry issue.

Ronan Collins

COMMUNICATIONS MANAGER

Whilst every effort is made to ensure the accuracy of theentries in this publication IPHA is not to be held liable indamages or otherwise for omissions or incorrect insertion,whether as to wording, space or position of any entry.

4

Introduction

SECTION ONE: MEDICINESMedicines in the Health SystemThe Medicines IndustryAbout IPHAInternational Associations

SECTION TWO: IPHA MEMBER COMPANIESMember Companies details including Media ContactsMember Company by Therapeutic Category

SECTION THREE: HEALTH CONTACTSHealthcare in Ireland TodayGovernment and Opposition Spokespersons for Health & ChildrenJoint Oireachtas Committee on Health and Children Department of Health and Children

About the Department of Health and ChildrenGovernment Health and Children MinistersDepartment of Health and Children DivisionsThe Role of Agencies in the Department of Health and ChildrenDepartment of Health and Children Statutory AgenciesDepartment of Health and Children Non-Statutory AgenciesHospital Boards

The Health Information and Quality Authority (HIQA)

Health Service Executive (HSE)About the HSEHSE Organisational StructureHSE BoardHSE Divisions

Regulatory AuthoritiesProfessional Healthcare OrganisationsVoluntary Health and Patient Organisations

7131923

2737

474851

5455568181848484

85

87888989

102102105

Contents

5

117118

120

123124125149

151153154

154161162163166167169

171172177178

SECTION FOUR: ENTERPRISE CONTACTSMedicines Industry in Ireland TodayGovernment and Opposition Spokespersons for Enterprise, Tradeand EmploymentJoint Oireachtas Committee on Enterprise Trade and Employment

Department of Enterprise Trade and Employment About the Department of Enterprise Trade and EmploymentGovernment Enterprise Trade and Employment MinistersDepartment of Enterprise Trade and Employment DivisionsDepartment of Enterprise Trade and Employment Agencies

European UnionMembers of the European ParliamentEuropean Union InstitutionsEuropean Union Agencies

Innovation and Translational MedicinesColleges of ResearchCentres for Science Engineering and TechnologyClinical Research CentresEthics CommitteesFacilitators/CollaborationsInvestorsFunding Agencies

SECTION FIVE: MEDIA CONTACTS

Specialised Medical and Health Print MediaNational and Sunday Print MediaTelevision Media ContactsRadio Media Contacts

The Stakeholder Handbook

6

Medicines

Section 1M

edicines

section one

“It is our duty to ensure that, in healthcare,new innovative medicines benefit as manypatients as possible, as quickly as possible –so that our true productivity, in terms ofpatient lives transformed, continues to rise.”

Dr Gerald Farrell, IPHA President

Medicines in the Health System

7


INNOVATIVE MEDICINES AND VACCINES

Innovative medicines and vaccines are an integral and increasinglyimportant part of the Irish healthcare system. They prevent, treatand cure disease, improve quality-of-life, control pain and sufferingand save lives. And, in the context of limited healthcare resources,access to medicines can empower patients to manage more of theirown care with timely, effective and convenient treatment.

The timely use of innovative medicines and vaccines has:

• Helped to improve life expectancy in Ireland by over a third inthe last eighty years, from 57 in 1925 to 79 today1.

• Enabled Irish hospitals to treat patients on a day case basis, from85,000 cases in 1987 to an estimated 590,000 in 20072.

• Helped thousands of Irish patients with Parkinson's, Alzheimer's,ulcers, cancer, diabetes and mental illness to lead better and morenormal lives, eliminated in some cases the need for costly,painful surgery, eased the burden on care-givers, delayed oravoided costly long-term nursing care and saved the Statemillions in healthcare costs.

• Contributed to reducing the number of deaths from heartdisease and stroke by nearly a half3 (the number one cause ofdeath in Ireland).

• Reduced the rate of death for heart attack patients in hospitalsby nearly 45% and the rate of subsequent heart attacks in aperiod of six months following initial treatment by 60% in just sixyears.4

• Helped to protect millions of people from disease, yet the searchcontinues for vaccines that will halt the spread of cancer anddiseases such as malaria and AIDS.

• Ensured that previously leading causes of death such aspneumonia, TB, polio and measles can now be successfullytreated globally.

81 CSO Statistics2 HSE Annual Report 20073 www.hse.ie/en/FactFileHome/HSEApproach/HSEModelofCare (accessed 24 October 2007)4 Journal of the American Medical Association

Section One – Medicines

The alternative to the use of innovative medicines is not cost free; itmay involve longer hospital stays, longer less effective treatments,invalidity, sick pay and a poorer quality of life.

The medicines bill in Ireland is low by international standards

Total State expenditure on medicines (2007)5 €1,703 million

Expenditure on medicines as a % of state health expenditure 10.9%

European average6 15.9%

There are straightforward reasons for the increase in the State billfor medicines in recent years:

• Ireland’s rapidly increasing and ageing population.

• The availability of newer, better medicines.

• Ireland’s low base of poor life expectancy and low levels ofutilisation of medicines.

• The increasing incidence of chronic and non-communicablediseases such as asthma, diabetes and obesity.

• State decisions to enhance eligibility and alter the administrationof certain community drug schemes, for example the decision togrant medical cards to everyone over 70 years old.

• The increasing research and development costs of new innovativemedicines, up from €344 million in 1987 to €1,059 million in20067.

95 Primary Care Reimbursement Service Annual Report 20076 EFPIA – The Pharmaceutical Industry in Figures 2007 Edition7 J.A. DiMasi and H.G. Grabowski, ‘The Cost of Biopharmaceutical R&D: Is Biotech Different?, Price of Innovation:

New Estimates of Drug Development Costs’, Managerial and Decision Economics 28 (2007): 469-479.


MEDICINES IN SELF-CARE

Consumers want to actively manage their own health and aretaking greater individual responsibility for their healthcare andhealth choices. The health, social and economic benefits ofresponsible self-medication are well known and have beenextensively reported8.

- Patients and consumers benefit due to wellness, enhancedproductivity and improved health in terms of prevention andincreased patient satisfaction as a result of being able to obtainthe correct medication directly.

- Employers gain by having employees attend work when theymight otherwise have stayed at home.

- General Practitioners save time which enables them to better usethat time for those patients with complicated or serious illnesses.A recent report estimated that 51.4 million GP consultations inthe UK were solely for minor ailments. It estimated that thisrepresented 18% of a GP’s workload. Furthermore it estimatedthat the total cost to the NHS of these consultations was €2.5billion and 80% of this cost (€2.15 billion) related to the cost ofthe GP’s time.9 It also presents more of an opportunity fordoctors to educate patients about common ailments anddiminishes patient expectations of a prescription for every visit.

- Pharmacists play a more active advisory role using their skilledknowledge of medicines and expertise in advising on symptoms.

- Consumers pay less visits to accident and emergency departmentsand doctor surgeries. This in turn reduces the number ofprescriptions, most of which are paid for, directly or indirectly, bythe State.

The basis of responsible self-medication is that the consumer has theappropriate information to select and use non-prescriptionmedicines correctly. To ensure that they realise that a safe andeffective remedy may be available for their minor ailment and do

108 E.g. Guiding Principles in Self-Medication: WSMI: http://www.wsmi.org/publications.htm 9 Minor ailments cost the NHS £2 billion/year. Pharm J 2008; 280:1090


11

not suffer in silence unnecessarily, appropriate information aboutnon-prescription medicines is provided to consumers through packinformation, advertising, public education initiatives and throughtheir pharmacist. These different information sources complementeach other and provide the appropriate safeguards to ensure thesafe use of self-medication products.


12

13

“Here in Ireland, we have placed R&D at the heartof our economic development strategy in recentyears.…The bottom line is that we in Ireland striveto become leaders in the global knowledgeeconomy. In order to do this, we will continue toinvest in the people and supports that have earnedus our reputation to date as a good place to dobusiness.”

Mr Bertie Ahern, Former Taoiseach

The Medicines Industry

13


PHARMA IRELAND

Ireland’s medicines industry currently generates nearly 50 percent of the country's exports which contributes to making Ireland thelargest net exporter of medicines in the world.

Direct Employment10

Employment in the sector has grown from 5,200 in 1988 24,500to 24,500 in 2007.Upwards of a further 24,500 jobs are based on the provision of services to the sector. Employment growth has exceeded 1,000 for each of the last nine years.Over half of the employees are third level graduates.

Pharmaceutical Exports11

Nearly €1 in every €6 worth of Irish exports in 2006 €14.8 billionconsisted of pharmaceutical and medical products.Using the broader pharmachem measure exports came to nearly €42.7 billion.Ireland is the largest net exporter of pharmaceuticalsin the world12.

1410 Pharmachemical Ireland11 CSO Statistics12 World Trade Organisation


1513 IPHA estimate based on an analysis of CSO and IDA Ireland data14 Ibid 11

World Trade in Pharmaceuticals 2005Country Exports $ Imports $ Balance $Ireland 17,994 2,484 15,510Switzerland 25,131 12,983 12,148Germany 37,506 30,097 7,409UK 22,487 15,964 6,523France 22,912 17,040 5,872Sweden 7,192 2,720 4,472Austria 4,507 4,207 300Netherlands 11,074 11,301 -227Italy 13,135 13,870 -735Belgium 35,024 35,804 -780Spain 5,933 8,844 -2,911Japan 3,327 8,204 -4,877USA 25,946 39,323 -13,377

Annual Taxation Payments13

These tax payments amount to nearly twice the €3 billionoverall State bill for medicines.

Replacement value of the investment by the pharmaceuticalsector in the Irish Economy14

13 of the top 15 companies in the world have €40 billionsubstantial operations in Ireland.

Nearly €7 billion has been invested by the sectorin Ireland over the last nine years.

“If Ireland is serious about meeting its objective ofincreasing its level of innovation, focus needs tocontinue to be placed on creating an environmentwhere investment is welcome, R&D is fostered, andinnovative ideas are valued and protected.”

Dr Gerald Farrell, IPHA President

16


PHARMA RESEARCH AND DEVELOPMENT

Research based pharmaceutical companies are the engines ofmedicines innovation. They have discovered and developed over90% of all new medicines made available to patients worldwideover the last twenty years.

The discovery, development, testing and gaining of regulatoryapproval for new medicines has become an even more highlycomplex, lengthy, risky and expensive process. Each success is builton many, many prior failures. On average only one or two of every10,000 promising substances will successfully pass extensive testing inthe R&D phase to be approved as a marketable product. As such thecost of developing a medicine has gone from €149 million in 1975 to€1,059 million in 200615.

COST OF DEVELOPING A NEW MEDICINE

It takes an average 10 to 12 years to develop a new medicine fromthe time it is discovered to when it passes the regulatory standards ofsafety, quality and efficacy and is available to patients. Once on themarket the average medicine has only 8 to 10 years of effectivepatent protection left before facing generic competition. Only threeout of ten marketed medicines produce revenues that match orexceed their R&D costs before they lose patent protection.

1715 J.A. DiMasi and H.G. Grabowski, ‘The Cost of Biopharmaceutical R&D: Is Biotech Different?, Price of Innovation:

New Estimates of Drug Development Costs’, Managerial and Decision Economics 28 (2007): 469-479.

0

200

400

600

800

1000

1200

Mill

ions

Year1975

149

1987

344

2001

868

2006

1,059


Innovation is central to the creation of the knowledge basedeconomy of the 21st century. For example in Ireland pharmaceuticalindustry R&D is responsible for 20% of all business R&D. If innovationis to flourish then it must be rewarded. Whilst Ireland retains a pro-innovation outlook this is increasingly not the case in Europegenerally with patient access to new medicines via Statereimbursement systems being delayed or even denied entirely. As aresult of this less favourable climate for innovation more and morepharmaceutical companies, including European ones, are decidingto locate new R&D facilities outside Europe.

18

Researchphase

10,000 molecules screened

From concept to product:steps in the genesis of a medicine

100 molecules tested

10 candidate molecules1 medicine

Testphase

5 years0 15 years 20 years

Patent filing Patent expiry

10 years R&D 2 to 3 years

Developmentphase

AdministrativeProcedures Commercialisation phase

10 years

“The wide availability and accessibility ofinnovative medicines allows greater choice andtherapeutic precision in healthcare and continuesto play an increasingly value-added role inhealthcare delivery.”

Ms Anne Nolan, IPHA Chief Executive

About IPHA

19


The mission of the Irish Pharmaceutical Healthcare Association (IPHA)is to create a favourable economic, regulatory and politicalenvironment which will enable the international research-basedpharmaceutical industry in Ireland to meet the growing healthcareneeds and expectations of patients.

IPHA aims also to develop an appreciation of the value of medicines,in particular innovative medicines, to healthcare and society as awhole thereby ensuring patients' continued, timely access to the fullrange of available medicines, regardless of their ability to pay.

IPHA represents the interests of the international research-based pharmaceutical industry:IPHA’s main activity is to ensure that the views and interests of theresearch based pharmaceutical industry are recognised by thoseinstitutions, at home and abroad, who are involved inpharmaceutical and healthcare matters.

Builds relationships with other partners in healthcare:IPHA maintains regular contacts with all relevant institutions in andoutside Ireland.

Participates in the healthcare decision making process:IPHA is regularly consulted in draft decisions made for example bythe Department of Health & Children and other Governmentagencies which relate to pharmaceutical and health matters.

Ensures the highest possible standards of advertising andpromotion:IPHA administers a number of Codes of Practice including the Codeof Marketing Practice for the Pharmaceutical Industry and the Codeof Advertising Standards for the Consumer Healthcare Industry. Theobjective of these Codes is to ensure the highest possible standard inadvertising and promotion of medicines.

Keeps the healthcare professions up-to-date:IPHA publishes the IPHA Medicines Compendium on CD-ROM everyyear for distribution free of charge, to members of the medical andpharmacy professions. As well as this IPHA maintain an onlineversion of the Compendium (www.medicines.ie). IPHA members arecommitted to supporting the continuing medical education ofhealthcare professionals.

20


Ensures supply of the full range of modern medicines:The members of IPHA have entered into a binding agreement withthe HSE to provide the best possible value for money in relation tothe purchasing of medicines for the health services in Ireland.

For more information, contact:

Irish Pharmaceutical Healthcare Association Franklin House140 Pembroke RoadBallsbridgeDublin 4Tel (+353) (0)1 660 3350Fax (+353) (0)1 668 6672Email: [email protected]

Anne NolanChief ExecutiveTel: (+353) (0)1 660 3350Email: [email protected]

Brian Murphy Director of Commercial AffairsTel: (+353) (0)1 663 0939Email: [email protected]

Dr Rebecca Cramp Scientific and Regulatory Affairs ManagerTel: (+353) (0)1 663 0932Email: [email protected]

Ronan CollinsCommunications ManagerTel: (+353) (0)1 663 0936Email: [email protected]

Michelle KurtzCommunications and Marketing ExecutiveTel: (+353) (0)1 663 0934Email: [email protected]

21


Sabine LouetHead of Code Services and InnovationTel: (+353) (0)1 663 0933Email: [email protected]

Visit our various websites:

22

www.ipha.ie www.medicines.ie

www.medicinesandyou.ie www.feelbetter.ie


INTERNATIONAL ASSOCIATIONS

Association of European Self-Medication Industry (AESGP) 7 Avenue de TervurenB-1040 BrusselsBelgiumTel: (+32) (2) 735 51 30Fax: (+32) (2) 735 52 22Email: [email protected]: www.aesgp.be

The Association of European Self-Medication Industry (AESGP) wasestablished in 1964 to contribute to the improvement of responsibleself-medication at a European level. AESGP comprises nationalorganizations (full members) and several associate membersrepresenting the main international companies operating in thearea of self-care, self-medication and food supplements. AESGPrepresents the interests of its members in a way that facilitatesconsumers’ access to high quality, safe and effective consumerhealthcare products.

Media ContactMs Mary CoronelCommunications and Public RelationsAESGP 7 Avenue de TervurenB-1040 BrusselsBelgiumTel: (+32) (0)2 735 51 30Fax: (+32) (0)2 735 52 22Email: [email protected]

23


European Federation of Pharmaceutical Industries and Associations(EFPIA) Leopold Plaza BuildingRue du Trône 108B-1050 BrusselsBelgium Tel: (+32) (0)2 626 25 55Fax: (+32) (0)2 626 25 66Email: [email protected]: www.efpia.eu

The European Federation of Pharmaceutical Industries andAssociations (EFPIA) has a direct membership of 32 nationalpharmaceutical industry associations and 43 leading pharmaceuticalcompanies. EFPIA represents about 2,200 companies in Europecommitted to researching and developing new medicines thatimprove health and quality of life around the world. The mission ofEFPIA is to improve the competitiveness of the research-basedpharmaceutical industry in Europe in a regulatory and politicalenvironment, which above all stimulates R&D and rewardsinnovation.

Media ContactColin MacKay Director of Communication and PartnershipsEFPIALeopold Plaza BuildingRue du Trône 108B-1050 BrusselsBelgium Tel: (+32) (0)2 626 25 55Fax: (+32) (0)2 626 25 66Email: [email protected]

24

International Federation of Pharmaceutical Manufacturers andAssociations (IFPMA)15 Ch. Louis-DunantPO Box 1951211 Geneva 20SwitzerlandTel: (+41) 22 338 32 00Fax: (+41) 22 338 32 99Email: [email protected]: www.ifpma.org

The International Federation of Pharmaceutical Manufacturers andAssociations (IFPMA) is an organisation representing 60 national orregional pharmaceutical industry associations and companies fromboth developed and developing countries. Member companies ofthe IFPMA are research-based pharmaceutical, biotech and vaccinecompanies. IFPMA strives to create a global environment thatfosters innovation, drug regulation, market-based competition inthe health care sector, the dissemination of drug information,ethical promotion of drugs, patient access to innovative therapiesand protection from substandard and counterfeit products.

Media ContactGuy Willis Director of CommunicationsIFPMA15 Ch Louis DunantPO Box 195 1211 Geneva 20SwitzerlandTel: (+41) 22 338 32 00Fax: (+41) 22 338 32 99Email: [email protected]

25


26

section two

IPHA Member Companies

Section 2IP

HA

Mem

ber Com

panies

Section Two – IPHA Member Companies

27

A Menarini PharmaceuticalsIreland LtdCastlecourtMonkstown FarmMonkstownCo Dublin Tel: (+353) (0)1 284 6744Fax: (+353) (0)1 284 6769Media ContactContact Main Number

Abbott Laboratories (I) Ltd4051 Kingswood DriveCitywest Business CampusDublin 24Tel: (+353) (0)1 469 1500Fax: (+353) (0)1 469 1501Primary Media ContactName: Carmel MulroyTel: (+353) (0)1 469 1500Mob : (+353) (0)86 605 8040Fax: (+353) (0)1 469 1538Email:[email protected]: Paula GuerinTel: (+353) (0)1 469 1586Fax: (+353) (0)1 469 1538Email: [email protected]

Allergan Pharmaceuticals IrelandLtd Castlebar RoadWestport Co. MayoTel: (+353) (0)98 25 222Fax: (+353) (0)98 25 792Website: www.allergan.comPrimary Media ContactName: Pat O’DonnellTel: (+353) (0)98 55 201Mob: (+353) (0)87 243 2594Fax: (+353) (0)98 26 744Email:[email protected]: Shauna CrossanTel: (+353) (0)98 55 419Mob: (+353) (0)87 616 5961Fax: (+353) (0)98 26 744Email:[email protected]

Alliance Pharmaceuticals IrelandAvonbridge HouseBath RoadChippenhamWiltshire SN15 2BBUKTel: (+44) 1 249 466 966Fax: (+44) 1 249 466 977Websitewww.alliancepharma.co.ukMedia ContactContact Main Number

MEMBER COMPANIES DETAILS INCLUDING MEDIACONTACTS

IPHA comprises of 53 research-based pharmaceutical companieswhich includes both manufacturers of prescription medicines andnon-prescription or consumer healthcare medicines. This sectioncontains all IPHA member companies and provides the point(s) ofcontact for media queries within each individual company.


Amgen Ireland Limited 21 Northwood CourtSantryDublin 9Tel: (+353) (0)1 852 7400Fax: (+353) (0)1 852 7499Media ContactName: Anette CondonMob: (+353) (0)87 284 1951Email: [email protected]

Astellas Pharma Ltd25 The Courtyard Kilcarbery Business ParkClondalkinDublin 22Tel: (+353) (0)1 467 1555Fax: (+353) (0)1 467 1550Media ContactName: Patricia KellyTel: (+353) (0)1 467 1555Fax: (+353) (0)1 467 1550

AstraZeneca Pharmaceuticals(Ireland) LtdCollege Park House20 Nassau StreetDublin 2Tel: (+353) (0)1 609 7100Fax: (+353) (0)1 679 6650Website: www.astrazeneca.comMedia ContactContact Main Number

Bayer Consumer CareThe AtriumBlackthorn RdSandyford EstateDublin 18Tel: (+353) (0)1 206 1445

Media ContactName: Niamh Griffin Tel: (+353) (0)1 299 9313Fax: (+353) (0)1 206 1456Email:[email protected]

Bayer Schering Pharma The AtriumBlackthorn RdSandyford EstateDublin 18Media ContactName: Niamh Griffin Tel: (+353) (0)1 299 9313Fax: (+353) (0)1 206 1456Email:[email protected]

Biogen Idec (Ireland) Ltd United Drug House Magna DriveMagna ParkCitywest RoadDublin 24 Tel: (+353) (0)1 463 7799Fax: (+353) (0)1 481 1730 Primary Media ContactName: Paula CobbTel: (+353) (0)1 463 7725Mob: (+353) (0)86 384 1973Fax: (+353) (0)1 481 1730Email:[email protected]: Siani BlanchfieldTel: (+353) (0)59 91 33017Mob: (+353) (0)87 243 4900Fax: (+353) (0)59 91 33519Email:[email protected]

28


Boehringer Ingelheim IrelandLimitedCorrig CourtCorrig RoadSandyford Industrial EstateDublin 18Tel: (+353) (0)1 295 9620Fax: (+353) (0)1 295 9624Media ContactContact Main Number

Bristol-Myers SquibbPharmaceuticalsSouth County Business ParkLeopardstownDublin 18Tel: (+353) (0)1 291 3800Fax: (+353) (0)1 291 3899Media ContactName: Fred DohertyTel: (+353) (0)1 291 3800Fax: (+353) (0)1 291 3899Email:[email protected]

Celgene LimtedMorgan HouseMadeira WalkSheet StreetWindsorBerkshireSL4 1BE UKTel: (+44) 1 753 498 600Fax: (+44) 1 753 861 484Media ContactName: Andrew RobertsonTel: (+44) 1 753 498 600Mob: (+44) 7 917 436 395Fax: (+44) 1 753 861 484Email: [email protected]

Cephalon Pharma (Ireland)LimitedUnit EGlencormack Business ParkKilmacanogueCo WicklowTel: (+353) (0)1 201 4000Fax: (+353) (0)1 201 4040Media ContactName: Marie-Dominique de LaSalleTel: (+33) 86 71 8248Fax: (+33) 86 71 8090Email:[email protected]

Eisai Limited3 ShortlandsHammersmith InternationalCentreLondon W6 8EEEnglandTel: (+44) 2 08 600 1400Fax: (+44) 2 08 600 1401Media ContactName: Andrew DayTel: (+44) 2 08 600 7395Mob: (+44) 7 973 411 419Fax: (+44) 2 08 600 7300Email: [email protected]

Eli Lilly & Company (Ireland) LtdHyde House65 Adelaide RoadDublin 2Tel: (+353) (0)1 661 4377Fax: (+353) (0)1 661 4476Media ContactContact Main Number

29


GlaxoSmithKlineStonemason’s WayRathfarnhamDublin 16Tel: (+353) (0)1 495 5000Fax: (+353) (0)1 495 5105Media ContactName: Claire TaaffeTel: (+353) (0)1 495 5218Mob: (+353) (0)86 805 3251Email: [email protected]

GlaxoSmithKlineConsumer HealthcareStonemason’s WayRathfarnhamDublin 16Tel: (+353) (0)1 495 5000Fax: (+353) (0)1 495 5105Media ContactName: Niall O’ SheaTel: (+353) (0)1 495 5208Mob: (+353) (0)86 170 1784Fax: (+353) (0)1 495 5575Email:[email protected]

Grünenthal Pharma LtdPharmapark ChapelizodDublin 20Tel: (+353) (0)1 630 5392Fax: (+353) (0)1 630 5317Media ContactName: Tom CooganTel: (+353) (0)1 630 5392Mob: (+353) (0)87 912 8560Fax: (+353) (0)1 630 5415Email:[email protected]

Helsinn Birex Therapeutics LtdUnit 5B DamastownMulhuddartDublin 15Tel: (+353) (0)1 822 5417 Fax: (+353) (0)1 822 5413(+353) (0)1 822 5410Media ContactContact Main Number

Ipsen Pharmaceuticals Limited7 Upper Leeson StreetDublin 4Tel: (+353) (0)1 668 1377Fax: (+353) (0)1 660 2818Primary Media ContactName: Alan Bass Tel: (+353) (0)1 668 1377Mob: (+353) (0)86 246 0420Fax: (+353) (0)1 660 2818Email: [email protected]: Susan Aughney Tel: (+353) (0)1 668 1377Mob: (+353) (0)86 260 2934Fax: (+353) (0)1 660 2818Email: [email protected]

Janssen-Cilag LimitedBlock BLiffey Valley Office ParkQuarryvaleCo. DublinTel: (+353) (0)1 623 1315Fax: (+353) (0)1 626 3592Media ContactName: Dr Leonie RynnTel (+353) (0)1 620 2308Mob: (+353) (0)87 833 9174Fax: (+353) (0)1 626 3592Email: [email protected]

30


SecondaryName: Dr Leisha DalyTel: (+353) (0)1 620 2302Mob: (+353) (0)87 677 7928Fax: (+353) (0)1 626 3592Email: [email protected]

Labopharm Europe Limited5 Seapoint Building44 Clontarf RoadDublin 3Tel: (+353) (0)1 854 0158Fax: (+353) (0)1 854 0144Website: www.labopharm.com Media ContactContact Main Number

LEO Pharma285 Cashel RoadDublin 12Tel: (+353) (0)1 490 8924Fax: (+353) (0)1 490 1606 Media ContactContact Main Number

Lundbeck (Ireland) Ltd7 RiverwalkCitywest Business CampusCitywestDubiln 24Tel: (+353) (0)1 468 9800Fax: (+353) (0)1 468 9850Primary Media ContactName: Darina Kelly Tel: (+353) (0)1 468 9800Mob: (+353) (0)86 852 0079Fax: (+353) (0)1 468 9850Email: [email protected]: Deirdre MoranTel: (+353) (0)1 468 9800Mob: (+353) (0)86 381 1805Fax: (+353) (0)1 468 9850Email: [email protected]

MEDAOffice 10Dunboyne Business ParkDunboyne Co MeathTel:(+353) (0)1 802 6624Fax: (+353) (0)1 802 6629Media ContactContact Main Number

Merck Serono 3013 Lake DriveCitywest Business CampusNaas RoadDublin 24Tel: (+353) (0)1 466 1910Fax: (+353) (0)1 466 1902Media ContactContact Main Number

Merck Sharp & Dohme Ireland(Human Health) LtdPelham HouseSouth County Business ParkLeopardstownDublin 18Tel: (+353) (0)1 299 8700Fax: (+353) (0)1 299 8701Media ContactName: Ciara O’ RourkeTel: (+353) (0)1 299 8706Mob: (+353) (0)86 388 7004Fax: (+353) (0)1 299 8701Email: [email protected]

31


Mundipharma PharmaceuticalsCompanyMillbank HouseArkle RoadSandyfordDublin 18Tel: (+353) (0)1 206 3800Fax: (+353) (0)1 294 5104Primary Media ContactName: Ian A. SuttonTel: (+353) (0)1 206 3800Fax: (+353) (0)1 294 5104Email:[email protected]: Rob CohenTel: (+44) 1 223 424 211Email:[email protected]

Novartis Consumer HealthRegus HouseHarcourt RoadDublin 2Tel: (+353) (0)1 477 3054Fax: (+353) (0)1 402 9448Media ContactContact Main Number

Novartis Ireland LtdBeech HouseBeech Hill Office CampusClonskeaghDublin 4Tel: (+353) (0)1 260 1255Fax: (+353) (0)1 260 1263Media ContactContact Main Number

Novo Nordisk Limited3-4 Upper Pembroke StreetDublin 2Tel: (+353) (0)1 678 5989Fax: (+353) (0)1 676 3259Primary Media ContactName: Owen TreacyTel: (+353) (0)1 678 5989Mob: (+353) (0)86 856 7224Fax: (+353) (0)1 676 3259Email: [email protected]: Yvette Murphy-SkovTel: (+353) (0)1 678 5989Mob: (+353) (0)86 850 0810Fax: (+353) (0)1 676 3259Email: [email protected]

Nycomed Products Ltd2051 Castle DriveCitywest Business CampusDublin 24Tel: (+353) (0)1 642 0021Fax: (+353) (0)1 642 0020 Media ContactContact Main Number

Organon Laboratories LimitedPO Box 2857Drynam RoadTel: (+353) (0)1 463 7400Fax: (+353) (0)1 459 6915Media ContactName: Brian DawsonTel: (+44) 1 223 432 704Mob: (+44) 7 887 630v975Fax: (+44) 1 223 432 700Email:[email protected]

32


McNeil HealthcareJohnson & Johnson Airton Road Tallaght Dublin 24 Tel: (+353) (0)1 466 5331Media ContactContact Main Number

Pfizer Healthcare IrelandNo.9River WalkCity West Business CampusDublin 24Tel: (+353) (0)1 467 6500Fax: (+353) (0)1 467 6501Media ContactName: Tara DelaneyTel: (+353) (0)1 467 6566Mob: (+353) (0)87 298 7958Fax: (+353) (0)1 467 6501Email:[email protected]

Pierre Fabre LtdHyde Abbey House23 Hyde StreetWinchesterHampshire5023 7DRUKTel: (+44) 1 962 874 400Fax: (+44) 1 962 844 014Media ContactContact Main Number

Procter & Gamble(Health & Beauty Care) LtdThe HeightsBrooklandsWeybridgeSurrey KT13 0XPUKTel: (+44) 1 932 896 000Fax: (+44) 1 932 896 200Media ContactContact Main Number

Reckitt Benckiser Healthcare(Ireland) Ltd7 RiverwalkCitywest Business CampusDublin 24Tel: (+353) (0)1 468 9200Fax: (+353) (0)1 468 9299 Media ContactName: Heather Ann McSharryTel: (+353) (0)1 468 9200Fax: (+353) (0)1 468 9299

Roche Products (Ireland) Ltd3004 Lake DriveCitywestNaas RoadDublin 24Tel: (+353) (0)1 469 0700Fax: (+353) (0)1 469 0790 Media ContactName: Sinéad O’ RoukeTel: (+353) (0)1 469 0700Mob: (+353) (0)86 044 1570Fax: (+353) (0)1 469 0790Email:[email protected]

33


Rottapharm LtdDamastown Industrial EstateMulhuddartDublin 15Tel: (+353) (0)1 885 2700Fax: (+353) (0)1 885 2792Media ContactContact Main Number

sanofi-aventis Ireland Ltd.18 RiverwalkNational Digital ParkCitywest Business CampusDublin 24Tel: (+353) (0)1 403 5600Fax: (+353) (0)1 403 5601Media ContactName: Sinead DuffyTel: (+353) (0)1 403 5643Mob: (+353) (0)86 600 8089Fax: (+353) (0)1 403 5603Email: [email protected]

Sanofi Pasteur MSDSecond FloorUnit A Cookstown CourtOld Belgard RoadTallaghtDublin 24Tel: (+353) (0)1 468 5600Fax: (+353) (0)1 420 3588Website: www.spmsd.co.ukMedia ContactContact Main Number

Schering Plough Pharmaceuticals(Ireland) Limited6th Floor,Block 14 (North Block)Rockfield CentralDundrumDublin 16Tel: (+353) (0)1 215 6030Fax: (+353) (0)1 215 6039Primary Media ContactName: Jim Baxter Tel: (+44) 1 707 363 990Mob: (+44) 7 768 498 522Fax: (+44) 1 707 363 958Email: [email protected]: Claire Beuster Tel: (+44) 1 707 363 986Fax: (+44) 1 707 363 958Email:[email protected]

Servier Laboratories (Ireland)LimitedBlock 2West Pier Business CampusOld Dunleary RoadDun LaoghaireCo DublinTel: (+353) (0)1 663 8110Fax: (+353) (0)1 663 8120Media ContactName: Dr Loic de ChasseyTel: (+353) (0)1 663 8110Mob: (+353) (0)86 837 4952Fax: (+353) (0)1 663 8120Email:[email protected]

34


Shire Pharmaceuticals Ireland Ltd5 RiverwalkCitywest Business CampusDublin 24Tel: (+353) (0)1 429 7700Fax: (+353) (0)1 429 7701Media ContactName: Jessica MannTel: (+44) 1 256 894 000Email: [email protected]

Solvay Healthcare LimitedUnited Drug HouseMagna Drive Magna Business Park Citywest RoadDublin 24Tel: (+353) (0)1 463 7387Fax: (+353) (0)1 463 7388Media ContactName: Martial TardyTel: (+32) 2 509 7230Mob: (+32) 475 830 114Fax: (+32) 2 509 72 40Email: [email protected] Name: Nicola MellotteTel: (+353) (0)1 463 7387Fax: (+353) (0)1 463 7388Email:[email protected]

SSL Healthcare Ireland LtdMonarch Industrial EstateBelgard RoadDublin 24Tel: (+353) (0)1 460 1925Fax: (+353) (0)1 460 3740Media ContactName: Miriam AbelTel: (+353) (0)1 460 1925Fax: (+353) (0)1 404 1666Email: [email protected]

Stiefel LaboratoriesHoltspur LaneWoodburn GreenHigh WycombeBucks HP10 0AUUKTel: (+44) 1 628 411 500 Fax: (+44) 1 628 810 021Media ContactContact Main Number

Tillotts Pharma Ltd25 Sandyford Office ParkDublin 18Tel: (+41) 619 352 614 Fax: (+41) 619 352 658Media ContactName: Mai HanlonTel: (+353) (0)1 294 2015Fax: (+353) (0)1 294 2019Email: [email protected]

UCB Pharma LimitedUnited Drug HouseMagna DriveCityWest RoadTallaght Dublin 24Tel: (+353) (0)1 463 7395Fax: (+353) (0)1 463 7396Media ContactName: Heather WilliamsTel: (+32) 2 599 933Email: [email protected]

35


Wyeth Consumer HealthcarePlaza 254Blanchardstown Corporate Park 2,BallycoolinBlanchardstownDublin 15Tel: (+353) (0)1 449 3500Fax: (+353) (0)1 449 3522Media ContactName: Geraldine O’ ConnorTel: (+353) (0)1 449 3500

Wyeth PharmaceuticalsPlaza 254Blanchardstown Corporate Park 2,BallycoolinBlanchardstownDublin 15Tel: (+353) (0)1 449 3500Fax: (+353) (0)1 449 3522Media ContactName: Geraldine O’ ConnorTel: (+353) (0)1 449 3500

36


ALIMENTARY SYSTEM

GeneralBayer Consumer CareMerck SeronoMerck Sharp & Dohme Ireland(Human Health) LtdRoche Products (Ireland) Ltd Shire Pharmaceuticals Ireland LtdLimitedSSL Healthcare Ireland Ltd

Antispasmodics(Anticholinergics)Boehringer Ingelheim IrelandLimited Solvay Healthcare Limited

DiarrhoeaJanssen-Cilag LimitedMcNeil Healthcare

Inflammatory Bowel DiseaseAstraZeneca Pharmaceuticals(Ireland) Ltd Biogen Idec (Ireland) LtdSchering-Plough Pharmaceuticals(Ireland) LimitedTillotts Pharma Ltd

LaxativesBoehringer Ingelheim IrelandLimitedMundipharma PharmaceuticalsCompanyProcter & Gamble (Health andBeauty Care) LtdReckitt Benckiser Healthcare(Ireland) LtdSolvay Healthcare Limited

Pancreatic EnzymesSolvay Healthcare Limited

Ulcer (Peptic Ulcers)Astellas Pharma LtdAstraZeneca Pharmaceuticals(Ireland) Ltd GlaxoSmithKline (GSK)Janssen-Cilag LimitedWyeth Pharmaceuticals

OtherBiogen Idec (Ireland) LtdGlaxoSmithKline (GSK)Janssen-Cilag Limited

CIRCULATORY SYSTEM

AnginaAbbott Laboratories (I) LtdBayer Schering PharmaBristol-Myers SquibbPharmaceuticalsCephalon Pharma (Ireland)LimitedMerck SeronoMundipharma PharmaceuticalsCompanyNovartis Ireland LtdServier Laboratories (Ireland)LimitedUCB Pharma Limited

37

MEMBER COMPANY BY THERAPEUTIC CATEGORY


HypertensionA. Menarini PharmaceuticalsIreland LtdAbbott Laboratories (I) LtdAstellas Pharma LtdAstraZeneca Pharmaceuticals(Ireland) Ltd Bayer Schering PharmaBoehringer Ingelheim IrelandLimited Bristol-Myers SquibbPharmaceuticalsMerck SeronoMerck Sharp & Dohme Ireland(Human Health) LtdMundipharma PharmaceuticalsCompanyNovartis Ireland LtdPfizer Healthcare Ireland Roche Products (Ireland) LtdServier Laboratories (Ireland)LimitedShire Pharmaceuticals Ireland LtdSolvay Healthcare Limited

DiureticsLEO PharmaMundipharma PharmaceuticalsCompanyNovartis Ireland LtdRoche Products (Ireland) Ltd Servier Laboratories (Ireland)Limited

Anticoagulants (Blood Thinners)Boehringer Ingelheim IrelandLimited LEO PharmaPfizer Healthcare IrelandWyeth Pharmaceuticals

Arrhythmia (Abnormal HeartRhythm)Abbott Laboratories (I) LtdAstraZeneca Pharmaceuticals(Ireland) Ltd Boehringer Ingelheim IrelandLimitedBristol-Myers SquibbPharmaceuticals

Myocardial Infarction (HeartAttack)Alliance Pharmaceuticals IrelandBoehringer Ingelheim IrelandLimited Bristol-Myers SquibbPharmaceuticalsMerck SeronoNovartis Ireland Ltd Roche Products (Ireland) LtdServier Laboratories (Ireland)LimitedSolvay Healthcare Limited

Congestive Heart FailureA. Menarini PharmaceuticalsIreland LtdAstraZeneca Pharmaceuticals(Ireland) Ltd Bristol-Myers SquibbPharmaceuticalsGlaxoSmithKline (GSK)Merck SeronoNovartis Ireland LtdPfizer Healthcare IrelandRoche Products (Ireland) Ltd Servier Laboratories (Ireland)LimitedSolvay Healthcare Limited

38


High CholesterolAstraZeneca Pharmaceuticals(Ireland) Ltd Bristol-Myers SquibbPharmaceuticalsMerck SeronoMerck Sharp & Dohme Ireland(Human Health) LtdNovartis Ireland Ltd Pfizer Healthcare IrelandSchering-Plough Pharmaceuticals(Ireland) LimitedSolvay Healthcare Limited

StrokeAllergan Pharmaceuticals IrelandLtdBoehringer Ingelheim IrelandLimited Cephalon Pharma (Ireland)Limited Ipsen Pharmaceuticals LimitedServier Laboratories (Ireland)LimitedUCB Pharma Limited

OtherGlaxoSmithKline (GSK)Roche Products (Ireland) Ltd

CNS

GeneralA. Menarini PharmaceuticalsIreland LtdBristol-Myers SquibbPharmaceuticalsGlaxoSmithKline (GSK)Ipsen Pharmaceuticals LimitedServier Laboratories (Ireland)Limited

DepressionAstellas Pharma LtdBoehringer Ingelheim IrelandLimited GlaxoSmithKline (GSK)Lundbeck (Ireland) Ltd Novartis Ireland Ltd Pfizer Healthcare IrelandRoche Products (Ireland) LtdSchering-Plough Pharmaceuticals(Ireland) LimitedSolvay Healthcare LimitedWyeth Pharmaceuticals

SchizophreniaAstraZeneca Pharmaceuticals(Ireland) Ltd Janssen-Cilag LimitedLundbeck (Ireland) Ltd Novartis Ireland LtdPfizer Healthcare Ireland

Alzheimer’s DiseaseLundbeck (Ireland) Ltd Novartis Ireland Ltd Pfizer Healthcare IrelandShire Pharmaceuticals Ireland Ltd

EpilepsyAstraZeneca Pharmaceuticals(Ireland) Ltd Cephalon Pharma (Ireland)LimitedEisai LimitedGlaxoSmithKline (GSK)Janssen-Cilag LimitedNovartis Ireland LtdPfizer Healthcare IrelandUCB Pharma Limited

39


InsomniaAstraZeneca Pharmaceuticals(Ireland) Ltd Bayer Schering PharmaWyeth Pharmaceuticals

Multiple Sclerosis Bayer Schering PharmaBiogen Idec (Ireland) LtdMerck Serono

Parkinson’s DiseaseBoehringer Ingelheim IrelandLimited GlaxoSmithKline (GSK)Lundbeck (Ireland) Ltd Roche Products (Ireland) LtdSolvay Healthcare LimitedUCB Pharma Limited

Sleep DisordersBayer Schering PharmaUCB Pharma Limited

Nausea GlaxoSmithKline (GSK)McNeil HealthcareMerck SeronoMerck Sharp & Dohme Ireland(Human Health) LtdReckitt Benckiser Healthcare(Ireland) LtdRoche Products (Ireland) Ltd Shire Pharmaceuticals Ireland LtdSSL Healthcare Ireland Ltd

Anxiety DisordersAstellas Pharma LtdAstraZeneca Pharmaceuticals(Ireland) Ltd Lundbeck (Ireland) Ltd Roche Products (Ireland) LtdWyeth Pharmaceuticals

Attention Deficit/HyperactivityDisorder (ADHD)Janssen-Cilag LimitedNovartis Ireland Ltd UCB Pharma Limited

-OtherAllergan Pharmaceuticals IrelandLtdGlaxoSmithKline (GSK)Lundbeck (Ireland) Ltd

ANALGESIA

Analgesics (Pain relievers)Abbott Laboratories (I) Ltd A.Menarini Pharmaceuticals IrelandLtdAstellas Pharma LtdAstraZeneca Pharmaceuticals(Ireland) Ltd Bayer Consumer CareBristol-Myers SquibbPharmaceuticalsCephalon Pharma (Ireland)LimitedEisai LimitedGlaxoSmithKline (GSK)Grüenthal Pharma LtdJanssen-Cilag LimitedMerck Sharp & Dohme Ireland(Human Health) LtdMundipharma PharmaceuticalsCompanyNovartis Ireland LtdPfizer Healthcare Ireland Reckitt Benckiser Healthcare(Ireland) LtdRoche Products (Ireland) LtdShire Pharmaceuticals Ireland LtdSSL Healthcare Ireland LtdUCB Pharma Limited Wyeth Consumer Healthcare

40


MigraineA. Menarini PharmaceuticalsIreland LtdAstraZeneca Pharmaceuticals(Ireland) Ltd GlaxoSmithKline (GSK)Janssen-Cilag LimitedReckitt Benckiser Healthcare(Ireland) LtdRoche Products (Ireland) Ltd

ANAESTHESIA

Abbott Laboratories (I) LtdAstraZeneca Pharmaceuticals(Ireland) Ltd Boehringer Ingelheim IrelandLimited GlaxoSmithKline (GSK)Janssen-Cilag LimitedSchering-Plough Pharmaceuticals(Ireland) Limited

RHEUMATOLOGY (rheumatoidarthristis, gout, muscle spasm)

Abbott Laboratories (I) LtdAlliance Pharmaceuticals IrelandAstellas Pharma LtdBoehringer Ingelheim IrelandLimited Bristol-Myers SquibbPharmaceuticalsMerck Sharp & Dohme Ireland(Human Health) LtdNovartis Ireland LtdRoche Products (Ireland) LtdRottapharm LimitedSchering-Plough Pharmaceuticals(Ireland) LimitedShire Pharmaceuticals Ireland LtdWyeth Pharmaceuticals

HORMONES

GeneralBristol-Myers SquibbPharmaceuticals

DiabetesBayer Schering PharmaGlaxoSmithKline (GSK)Merck SeronoMerck Sharp & Dohme Ireland(Human Health) LtdNovartis Ireland Ltd Pfizer Healthcare IrelandServier Laboratories (Ireland)LimitedSolvay Healthcare Limited

Erectile DysfunctionBayer Schering PharmaPfizer Healthcare Ireland

Hormone ReplacementAstraZeneca Pharmaceuticals(Ireland) Ltd Bayer Schering PharmaJanssen-Cilag LimitedNovartis Ireland LtdSolvay Healthcare LimitedWyeth Pharmaceuticals

Human Growth HormoneIpsen Pharmaceuticals LimitedMerck SeronoPfizer Healthcare Ireland

OtherGlaxoSmithKline (GSK)Ipsen Pharmaceuticals Limited

41


UROLOGY (genital infections,urinary tract infections, renaland bladder disorders)

Abbott Laboratories (I) LtdAmgen Ireland LimitedAstellas Pharma LtdGlaxoSmithKline (GSK)Ipsen Pharmaceuticals LimitedJanssen-Cilag LimitedLEO PharmaPfizer Healthcare IrelandRoche Products (Ireland) Ltd Shire Pharmaceuticals Ireland LtdUCB Pharma Limited

ANTI-INFECTIVES

GeneralProcter & Gamble (Health andBeauty Care) LtdSolvay Healthcare Limited

Antibacterial (Antibiotics)Abbott Laboratories (I) LtdAlliance Pharmaceuticals IrelandAstraZeneca Pharmaceuticals(Ireland) Ltd Bayer Schering PharmaGlaxoSmithKline (GSK)Grüenthal Pharma LtdNovartis Ireland LtdPfizer Healthcare IrelandRoche Products (Ireland) Ltd

Antifungal (Fungal systemic)Bayer Consumer CareCephalon Pharma (Ireland)LimitedJanssen-Cilag LimitedMcNeil Healthcare

Novartis Ireland LtdPfizer Healthcare IrelandReckitt Benckiser Healthcare(Ireland) LtdSchering-Plough Pharmaceuticals(Ireland) LimitedServier Laboratories (Ireland)LimitedUCB Pharma Limited

AntiviralAbbott Laboratories (I) LtdAstraZeneca Pharmaceuticals(Ireland) Ltd Bristol-Myers SquibbPharmaceuticalsGlaxoSmithKline (GSK)Pfizer Healthcare IrelandRoche Products (Ireland) LtdSchering-Plough Pharmaceuticals(Ireland) LimitedWyeth Pharmaceuticals

HIV Infection/AidsAbbott Laboratories (I) LtdBoehringer Ingelheim IrelandLimitedBristol-Myers SquibbPharmaceuticalsGlaxoSmithKline (GSK)Janssen-Cilag LimitedMerck Sharp & Dohme Ireland(Human Health) LtdPfizer Healthcare IrelandRoche Products (Ireland) Ltd

42


IMMUNOLOGY

VaccinesGlaxoSmithKline (GSK)Procter & Gamble (Health andBeauty Care) LtdSanofi Pasteur MSDSolvay Healthcare LimitedWyeth Pharmaceuticals

Immunosuppressants A. Menarini Pharmaceuticals Abbott Laboratories (I) LtdAlliance Pharmaceuticals IrelandAstellas Pharma LtdGlaxoSmithKline (GSK)Novartis Ireland Ltd Wyeth Pharmaceuticals

DIETETICS (vitamins anddietary supplements, anti-obesity, anaemia)

A. Menarini PharmaceuticalsIreland LtdAbbott Laboratories (I) LtdAmgen Ireland LimitedAllergan Pharmaceuticals IrelandLtdBoehringer Ingelheim IrelandLimitedBristol-Myers SquibbPharmaceuticalsJanssen-Cilag LimitedNovartis Consumer HealthNovartis Ireland LimitedRoche Products (Ireland) Ltd Shire Pharmaceuticals Ireland LtdSSL Healthcare Ireland LtdUCB Pharma LimitedLEO Pharma

RESPIRATORY

AsthmaAstellas Pharma LtdAstraZeneca Pharmaceuticals(Ireland) LtdBoehringer Ingelheim IrelandLimited GlaxoSmithKline (GSK)Merck Sharp & Dohme Ireland(Human Health) LtdNovartis Ireland Ltd

Chronic Obstructive PulmonaryDiseaseAstraZeneca Pharmaceuticals(Ireland) Ltd Bayer Schering PharmaBoehringer Ingelheim IrelandLimited GlaxoSmithKline (GSK)Mundipharma PharmaceuticalsCompanyPfizer Healthcare Ireland

Cystic FibrosisBayer Schering PharmaNovartis Ireland LtdRoche Products (Ireland) Ltd

Cough and ColdGlaxoSmithKline (GSK)Procter and Gamble (Health andBeauty Care) LtdReckitt Benckiser Healthcare(Ireland) LtdWyeth Consumer Healthcare

43


OTOLARYNGOLOGY (ear, noseand throat)

Alliance Pharmaceuticals IrelandAstraZeneca Pharmaceuticals(Ireland) LtdBoehringer Ingelheim IrelandLimited Bristol-Myers SquibbPharmaceuticalsGlaxoSmithKline (GSK)Janssen-Cilag LimitedMedaNovartis Consumer HealthNovartis Ireland LimitedPfizer Healthcare IrelandReckitt BenckiserRoche Products (Ireland) Ltd Schering-Plough Pharmaceuticals(Ireland) LimitedServier Laboratories (Ireland)LimitedSSL Healthcare Ireland LtdUCB Pharma Limited

OPHTHALMOLOGY (eye)

Allergan Pharmaceuticals IrelandLtdIpsen Pharmaceuticals LimitedLEO PharmaMerck Sharp & Dohme Ireland(Human Health) LtdNovartis Ireland Ltd Pfizer Healthcare IrelandReckitt Benckiser Healthcare(Ireland) LtdRoche Products (Ireland) Ltd UCB Pharma Limited

ALLERGY

A. Menarini PharmaceuticalsIreland Ltd AstraZeneca Pharmaceuticals(Ireland) LtdGlaxoSmithKline (GSK)Schering-Plough Pharmaceuticals(Ireland) LimitedUCB Pharma Limited

DERMATOLOGY (psoriasis,eczema, acne, scabies)

Abbott Laboratories (I) LtdAllergan Pharmaceuticals IrelandLtdAlliance Pharmaceuticals IrelandAstellas Pharma LtdBayer Consumer CareBayer Schering Pharma Cephalon Pharma (Ireland)Limited GlaxoSmithKline (GSK)Janssen-Cilag LimitedLEO PharmaMerck SeronoNovartis Ireland LtdPierre Fabre LtdReckitt Benckiser Healthcare(Ireland) LtdRoche Products (Ireland) LtdSchering-Plough Pharmaceuticals(Ireland) LimitedShire Pharmaceuticals Ireland LtdSSL Healthcare Ireland LtdStiefel LaboratoriesUCB Pharma Limited Wyeth Pharmaceuticals

44


CONTRACEPTION

Bayer Schering PharmaJanssen-Cilag LimitedSchering-Plough Pharmaceuticals(Ireland) LimitedSSL Healthcare Ireland LtdWyeth Pharmaceuticals

OBSTETRICS & GYNAECOLOGY

Breast DisordersAstraZeneca Pharmaceuticals(Ireland) Ltd Bristol-Myers SquibbPharmaceuticalsMedaNovartis Ireland LtdPfizer Healthcare IrelandRoche Products (Ireland) Ltd

Hormone ReplacementAstraZeneca Pharmaceuticals(Ireland) Ltd Bayer Schering PharmaJanssen-Cilag LimitedNovartis Ireland LtdSolvay Healthcare LimitedWyeth Pharmaceuticals

Osteoporosis A. Menarini PharmaceuticalsIreland LtdAmgen Ireland LimitedGlaxoSmithKline (GSK)Merck Sharp & Dohme Ireland(Human Health) LtdPfizer Healthcare IrelandRoche Products (Ireland) LtdServier Laboratories (Ireland)Limited

Shire Pharmaceuticals Ireland LtdWyeth Consumer HealthcareWyeth Pharmaceuticals

ObstetricsAstraZeneca Pharmaceuticals(Ireland) Ltd Novartis Ireland LtdPfizer Healthcare Ireland

Reproductive HealthIpsen Pharmaceuticals LimitedMedaMerck SeronoPfizer Healthcare IrelandSchering-Plough Pharmaceuticals(Ireland) Limited

OtherBayer Schering Pharma Ipsen Pharmaceuticals Limited

ONCOLOGY (cancer)

Amgen Ireland Limited Astellas Pharma LtdAstraZeneca Pharmaceuticals(Ireland) Ltd Bayer Schering PharmaBiogen Idec (Ireland) LtdBristol-Myers SquibbPharmaceuticalsCelgene LimitedCephalon Pharma (Ireland)LimitedGlaxoSmithKline (GSK)Ipsen Pharmaceuticals LimitedJanssen-Cilag LimitedMerck SeronoNovartis Ireland LtdPfizer Healthcare Ireland

45


46

Pierre Fabre LtdProcter & Gamble (Health andBeauty Care) LtdRoche Products (Ireland) LtdSanofi Pasteur MSDSchering-Plough Pharmaceuticals(Ireland) LimitedWyeth Pharmaceuticals

NICOTINE REPLACEMENT

GlaxoSmithKline (GSK)McNeil HealthcareNovartis Consumer HealthPfizer Healthcare Ireland

TOXICOLOGY

Alliance Pharmaceuticals IrelandBristol-Myers SquibbPharmaceuticalsGlaxoSmithKline (GSK)LEO PharmaMerck SeronoNovartis Ireland LtdRoche Products (Ireland) LtdUCB Pharma Ltd

DIAGNOSTIC AGENTS(imaging)

Bayer Schering Pharma

the ipha stakeholder handbook - section 1 to 2

Documents

children department

health information

health contactshealthcare

childrengovernment health

childrendepartment of

healthcare sectors

industry issue

tothe industry